Your browser doesn't support javascript.
loading
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.
Baliakas, Panagiotis; Mattsson, Mattias; Hadzidimitriou, Anastasia; Minga, Eva; Agathangelidis, Andreas; Sutton, Lesley-Ann; Scarfo, Lydia; Davis, Zadie; Yan, Xiao-Jie; Plevova, Karla; Sandberg, Yorick; Vojdeman, Fie J; Tzenou, Tatiana; Chu, Charles C; Veronese, Silvio; Mansouri, Larry; Smedby, Karin E; Giudicelli, Véronique; Nguyen-Khac, Florence; Panagiotidis, Panagiotis; Juliusson, Gunnar; Anagnostopoulos, Achilles; Lefranc, Marie-Paule; Trentin, Livio; Catherwood, Mark; Montillo, Marco; Niemann, Carsten U; Langerak, Anton W; Pospisilova, Sarka; Stavroyianni, Niki; Chiorazzi, Nicholas; Oscier, David; Jelinek, Diane F; Shanafelt, Tait; Darzentas, Nikos; Belessi, Chrysoula; Davi, Frederic; Ghia, Paolo; Rosenquist, Richard; Stamatopoulos, Kostas.
Afiliação
  • Baliakas P; Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
  • Mattsson M; Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
  • Hadzidimitriou A; Department of Hematology, Uppsala University Hospital, Sweden.
  • Minga E; Institute of Applied Biosciences, Thessaloniki, Greece.
  • Agathangelidis A; Institute of Applied Biosciences, Thessaloniki, Greece.
  • Sutton LA; Institute of Applied Biosciences, Thessaloniki, Greece.
  • Scarfo L; Università Vita-Salute San Raffaele, Milan, Italy.
  • Davis Z; Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Yan XJ; Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
  • Plevova K; Università Vita-Salute San Raffaele, Milan, Italy.
  • Sandberg Y; Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Vojdeman FJ; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Tzenou T; The Feinstein Institute for Medical Research, Northwell Health, New York, USA.
  • Chu CC; CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic.
  • Veronese S; University Hospital Brno, Czech Republic.
  • Mansouri L; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
  • Smedby KE; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Giudicelli V; First Department of Propaedeutic Medicine, University of Athens, Greece.
  • Nguyen-Khac F; The Feinstein Institute for Medical Research, Northwell Health, New York, USA.
  • Panagiotidis P; Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy.
  • Juliusson G; Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
  • Anagnostopoulos A; Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, and Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
  • Lefranc MP; IMGT®, the international ImMunoGeneTics information system®, Université de Montpellier, Laboratoire d'ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, Montpellier, France.
  • Trentin L; Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France.
  • Catherwood M; First Department of Propaedeutic Medicine, University of Athens, Greece.
  • Montillo M; Lund University and Hospital Department of Hematology, Lund Stem Cell Center, Sweden.
  • Niemann CU; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Langerak AW; IMGT®, the international ImMunoGeneTics information system®, Université de Montpellier, Laboratoire d'ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, Montpellier, France.
  • Pospisilova S; Department of Medicine, Hematology and Clinical Immunology Branch, Padova University School of Medicine, Italy.
  • Stavroyianni N; Venetian Institute of Molecular Medicine, Padova, Italy.
  • Chiorazzi N; Department of Hemato-Oncology, Belfast City Hospital, Belfast, UK.
  • Oscier D; Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy.
  • Jelinek DF; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Shanafelt T; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
  • Darzentas N; CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic.
  • Belessi C; University Hospital Brno, Czech Republic.
  • Davi F; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Ghia P; The Feinstein Institute for Medical Research, Northwell Health, New York, USA.
  • Rosenquist R; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Stamatopoulos K; Department of Immunology, Mayo Clinic, Rochester, MV, USA.
Haematologica ; 103(4): e158-e161, 2018 04.
Article em En | MEDLINE | ID: mdl-29269523
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Tratamento Farmacológico / Imunoterapia Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Tratamento Farmacológico / Imunoterapia Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia